Abeona Therapeutics - 41 Year Stock Price History | ABEO

Historical daily share price chart and data for Abeona Therapeutics since 1984 adjusted for splits and dividends. The latest closing stock price for Abeona Therapeutics as of November 10, 2025 is 4.23.
  • The all-time high Abeona Therapeutics stock closing price was 1000000.00 on November 05, 1984.
  • The Abeona Therapeutics 52-week high stock price is 7.54, which is 78.3% above the current share price.
  • The Abeona Therapeutics 52-week low stock price is 3.93, which is 7.1% below the current share price.
  • The average Abeona Therapeutics stock price for the last 52 weeks is 5.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abeona Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 5.7427 5.9100 7.2300 4.1800 4.2300 -24.06%
2024 5.6981 5.5300 8.6800 3.1700 5.5700 11.18%
2023 3.5779 2.8600 5.2700 2.2500 5.0100 62.66%
2022 4.9356 9.2500 9.2500 2.4000 3.0800 -63.44%
2021 36.3303 42.2500 84.7500 7.1675 8.4250 -78.54%
2020 58.1428 80.2500 102.0000 25.5000 39.2500 -51.99%
2019 122.1265 175.7500 207.7500 38.5000 81.7500 -54.20%
2018 345.4885 430.0000 536.2500 160.0000 178.5000 -54.95%
2017 237.3506 125.0000 498.7500 115.0000 396.2500 226.80%
2016 97.3688 85.5000 217.5000 52.5000 121.2500 44.35%
2015 116.2187 85.0000 245.0000 69.2500 84.0000 -2.61%
2014 396.6140 312.5000 735.0000 86.0000 86.2500 -72.40%
2013 509.2676 337.5000 750.0000 287.5000 312.5000 4.17%
2012 938.2340 1750.0000 1800.0000 275.0000 300.0000 -83.33%
2011 2509.3900 3087.5000 3237.5000 1650.0000 1800.0000 -41.94%
2010 3116.8825 4000.0000 4112.5000 2250.0000 3100.0000 -24.62%
2009 2961.2902 1125.0000 5875.0000 962.5000 4112.5000 232.32%
2008 3017.1508 4275.0000 4375.0000 1000.0000 1237.5000 -69.54%
2007 5737.4452 3625.0000 12825.0000 3000.0000 4062.5000 16.07%
2006 1671.0689 3187.5000 3687.5000 125.0000 3500.0000 7.69%
2005 11160.7893 21500.0000 21750.0000 3250.0000 3250.0000 -85.31%
2004 31038.9758 32437.5000 49687.5000 15812.5000 22125.0000 -32.44%
2003 20144.0972 11562.5000 34375.0000 10937.5000 32750.0000 249.33%
2002 16784.9190 27812.5000 35312.5000 7187.5000 9375.0000 -66.22%
2001 23348.8528 31250.0000 39062.5000 14375.0000 27750.0000 -11.20%
2000 33367.1446 10027.2000 79501.3000 9310.9600 31250.0000 172.70%
1999 13598.1073 13608.3000 23277.4000 6625.1100 11459.6000 -11.11%
1998 24421.5600 63028.1000 80217.5000 6446.0500 12892.1000 -79.55%
1997 64814.6604 89528.5000 139664.0000 22919.3000 63028.1000 -26.67%
1996 171570.2502 121759.0000 307978.0000 85947.4000 85947.4000 -29.41%
1995 63679.8272 68041.7000 128921.0000 28649.1000 121759.0000 88.89%
1994 107079.0414 136083.0000 200544.0000 50136.0000 64460.5000 -55.00%
1993 241897.4921 358114.0000 386763.0000 128921.0000 143246.0000 -54.55%
1992 519789.3701 687808.0000 1000000.0000 286491.0000 315140.0000 -54.18%
1991 340085.6706 128921.0000 795013.0000 121931.0000 687808.0000 448.75%
1990 256676.5992 300816.0000 422575.0000 118178.0000 125340.0000 -53.95%
1989 762753.9721 630281.0000 1000000.0000 207878.0000 272167.0000 -56.82%
1988 810675.5415 773526.0000 1000000.0000 544333.0000 630281.0000 -12.00%
1987 964835.3399 1000000.0000 1000000.0000 601632.0000 716228.0000 -28.38%
1986 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1985 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.215B $0.004B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $262.317B 18.51
Amgen (AMGN) United States $172.422B 14.64
Gilead Sciences (GILD) United States $147.457B 14.51
Vertex Pharmaceuticals (VRTX) United States $103.890B 26.75
Bristol Myers Squibb (BMY) United States $95.049B 7.12
GSK (GSK) United Kingdom $94.678B 10.53
Regeneron Pharmaceuticals (REGN) United States $69.106B 17.93
Alnylam Pharmaceuticals (ALNY) United States $58.487B 1924.78
CSL (CSLLY) Australia $56.375B 0.00
Argenex SE (ARGX) Netherlands $52.620B 65.34
Insmed (INSM) United States $40.458B 0.00
Novozymes (NVZMY) Denmark $30.060B 0.00
BioNTech SE (BNTX) Germany $24.801B 0.00
Biogen (BIIB) United States $22.814B 9.29
Royalty Pharma (RPRX) United States $22.487B 8.53
Incyte (INCY) United States $20.806B 19.92
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.626B 27.96
Genmab (GMAB) Denmark $18.402B 13.85
Roivant Sciences (ROIV) United Kingdom $14.081B 0.00
Exact Sciences (EXAS) United States $12.539B 348.32
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.200B 0.00
Guardant Health (GH) United States $12.191B 0.00
Revolution Medicines (RVMD) United States $11.794B 0.00
Exelixis (EXEL) United States $10.942B 17.51
Avidity Biosciences (RNA) United States $10.190B 0.00
BioMarin Pharmaceutical (BMRN) United States $9.886B 17.93
QIAGEN (QGEN) Netherlands $9.683B 18.38
Moderna (MRNA) United States $9.587B 0.00
Bio-Techne Corp (TECH) United States $8.945B 33.38
Metsera (MTSR) United States $8.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Abivax SA (ABVX) France $8.193B 0.00
Repligen (RGEN) United States $8.039B 86.04
Halozyme Therapeutics (HALO) United States $8.025B 12.83
Jazz Pharmaceuticals (JAZZ) Ireland $7.970B 31.08
Cytokinetics (CYTK) United States $7.355B 0.00
Merus (MRUS) Netherlands $7.223B 0.00
Axsome Therapeutics (AXSM) United States $6.965B 0.00
Nuvalent (NUVL) United States $6.787B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.694B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.438B 0.00
Legend Biotech (LEGN) United States $5.869B 0.00
PTC Therapeutics (PTCT) United States $5.763B 7.83
Krystal Biotech (KRYS) United States $5.739B 29.67
Vaxcyte (PCVX) United States $5.452B 0.00
Alkermes (ALKS) Ireland $5.431B 15.97
Arrowhead Pharmaceuticals (ARWR) United States $5.424B 0.00
TG Therapeutics (TGTX) United States $5.118B 11.60
CRISPR Therapeutics AG (CRSP) Switzerland $5.013B 0.00
Arcellx (ACLX) United States $5.005B 0.00
Protagonist Therapeutics (PTGX) United States $4.973B 128.29
Zealand Pharma (ZLDPF) Denmark $4.769B 4.72
Akero Therapeutics (AKRO) United States $4.323B 0.00
Kymera Therapeutics (KYMR) United States $4.221B 0.00
Praxis Precision Medicines (PRAX) United States $4.207B 0.00
Viking Therapeutics (VKTX) United States $4.156B 0.00
Immunovant (IMVT) United States $4.070B 0.00
Ligand Pharmaceuticals (LGND) United States $3.968B 97.82
ACADIA Pharmaceuticals (ACAD) United States $3.818B 32.24
Belite Bio (BLTE) United States $3.604B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.500B 0.00
ADMA Biologics Inc (ADMA) United States $3.465B 24.61
Telix Pharmaceuticals (TLX) Australia $3.287B 0.00
Celcuity (CELC) United States $3.162B 0.00
CG Oncology (CGON) United States $3.026B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.968B 0.00
Ascentage Pharma Group - (AAPG) China $2.961B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.956B 0.00
Jyong Biotech (MENS) Taiwan $2.955B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.955B 0.00
Disc Medicine (IRON) United States $2.915B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.908B 85.27
Tarsus Pharmaceuticals (TARS) United States $2.897B 0.00
Travere Therapeutics (TVTX) United States $2.894B 0.00
GRAIL (GRAL) United States $2.862B 0.00
Scholar Rock Holding (SRRK) United States $2.783B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 221.75
IDEAYA Biosciences (IDYA) United States $2.651B 0.00
Cidara Therapeutics (CDTX) United States $2.647B 0.00
Viridian Therapeutics (VRDN) United States $2.619B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.608B 0.00
Apogee Therapeutics (APGE) United States $2.523B 0.00
Mineralys Therapeutics (MLYS) United States $2.521B 0.00
Anbio Biotechnology (NNNN) Germany $2.461B 0.00
Zai Lab (ZLAB) China $2.448B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 62.13
Agios Pharmaceuticals (AGIO) United States $2.372B 0.00
Bavarian Nordic (BVNRY) Denmark $2.308B 11.16
Liquidia (LQDA) United States $2.270B 0.00
Adaptive Biotechnologies (ADPT) United States $2.258B 0.00
Beam Therapeutics (BEAM) United States $2.254B 0.00
Denali Therapeutics (DNLI) United States $2.203B 0.00
ImmunityBio (IBRX) United States $2.098B 0.00
Arcus Biosciences (RCUS) United States $2.085B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.006B 0.00
Vericel (VCEL) United States $1.969B 162.25
ANI Pharmaceuticals (ANIP) United States $1.962B 15.75
Structure Therapeutics (GPCR) United States $1.892B 0.00
Mesoblast (MESO) Australia $1.874B 0.00
Twist Bioscience (TWST) United States $1.827B 0.00
Edgewise Therapeutics (EWTX) United States $1.817B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.810B 9.88
MannKind (MNKD) United States $1.729B 56.30
Sarepta Therapeutics (SRPT) United States $1.723B 0.00
Alvotech (ALVO) Luxembourg $1.721B 12.98
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Cogent Biosciences (COGT) United States $1.687B 0.00
Nuvation Bio (NUVB) United States $1.622B 0.00
Terns Pharmaceuticals (TERN) United States $1.616B 0.00
Janux Therapeutics (JANX) United States $1.591B 0.00
Sionna Therapeutics (SION) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
UniQure (QURE) Netherlands $1.525B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Zenas BioPharma (ZBIO) United States $1.415B 0.00
Certara (CERT) United States $1.393B 25.50
Maze Therapeutics (MAZE) United States $1.375B 0.00
Spyre Therapeutics (SYRE) United States $1.360B 0.00
Trevi Therapeutics (TRVI) United States $1.341B 0.00
Immunome (IMNM) United States $1.327B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.307B 0.00
Stoke Therapeutics (STOK) United States $1.306B 34.12
NeoGenomics (NEO) United States $1.304B 0.00
Dynavax Technologies (DVAX) United States $1.272B 37.35
WAVE Life Sciences (WVE) Singapore $1.251B 0.00
Upstream Bio (UPB) United States $1.241B 0.00
Zymeworks (ZYME) United States $1.237B 0.00
NovoCure (NVCR) Jersey $1.223B 0.00
Novavax (NVAX) United States $1.209B 3.07
Oric Pharmaceuticals (ORIC) United States $1.199B 0.00
Inhibrx Biosciences (INBX) United States $1.169B 0.00
CureVac (CVAC) Germany $1.169B 5.43
AbCellera Biologics (ABCL) Canada $1.168B 0.00
Dianthus Therapeutics (DNTH) United States $1.168B 0.00
Precigen (PGEN) United States $1.162B 0.00
Pharvaris (PHVS) Netherlands $1.129B 0.00
MiMedx (MDXG) United States $1.102B 19.58
Immatics (IMTX) Germany $1.100B 0.00
AnaptysBio (ANAB) United States $1.098B 0.00
Urogen Pharma (URGN) United States $1.088B 0.00
Tango Therapeutics (TNGX) United States $1.059B 0.00
Pharming Group (PHAR) Netherlands $1.057B 0.00
Fortrea Holdings (FTRE) United States $1.040B 22.06
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Intellia Therapeutics (NTLA) United States $1.022B 0.00
Oculis Holding AG (OCS) Switzerland $1.007B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.999B 0.00
Pacira BioSciences (PCRX) United States $0.991B 10.86
Rezolute (RZLT) United States $0.977B 0.00
Sana Biotechnology (SANA) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.964B 132.16
BridgeBio Oncology Therapeutics (BBOT) United States $0.962B 0.00
Nanobiotix S.A - (NBTX) France $0.953B 0.00
Nurix Therapeutics (NRIX) United States $0.946B 0.00
BGM Group (BGM) China $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.943B 0.00
Rapport Therapeutics (RAPP) United States $0.937B 0.00
Kodiak Sciences (KOD) United States $0.931B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.928B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Iovance Biotherapeutics (IOVA) United States $0.913B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.890B 0.00
Biohaven (BHVN) United States $0.874B 0.00
Arbutus Biopharma (ABUS) United States $0.863B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.859B 0.00
Kura Oncology (KURA) United States $0.858B 0.00
CorMedix Inc (CRMD) United States $0.843B 14.35
Septerna (SEPN) United States $0.825B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.802B 38.47
Bicara Therapeutics (BCAX) United States $0.800B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
Tyra Biosciences (TYRA) United States $0.764B 0.00
ArriVent BioPharma (AVBP) United States $0.732B 0.00
LENZ Therapeutics (LENZ) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Gyre Therapeutics (GYRE) United States $0.694B 90.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.683B 0.00
Arvinas (ARVN) United States $0.683B 0.00
Geron (GERN) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Replimune (REPL) United States $0.652B 0.00
MapLight Therapeutics (MPLT) $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Erasca (ERAS) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.626B 0.00
Ventyx Biosciences (VTYX) United States $0.625B 0.00
CytomX Therapeutics (CTMX) United States $0.613B 9.05
Cytek Biosciences (CTKB) United States $0.591B 0.00
Myriad Genetics (MYGN) United States $0.587B 0.00
Compass Therapeutics (CMPX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.568B 0.00
REGENXBIO (RGNX) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.558B 0.00
Gossamer Bio (GOSS) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.546B 42.75
Verastem (VSTM) United States $0.539B 0.00
Emergent Biosolutions (EBS) United States $0.534B 5.13
Ginkgo Bioworks Holdings (DNA) United States $0.530B 0.00
Prime Medicine (PRME) United States $0.513B 0.00
Monopar Therapeutics (MNPR) United States $0.499B 0.00
Absci (ABSI) United States $0.499B 0.00
Keros Therapeutics (KROS) United States $0.494B 10.52
Alumis (ALMS) United States $0.491B 0.00
Rapt Therapeutics (RAPT) United States $0.477B 0.00
DBV Technologies S.A (DBVT) France $0.473B 0.00
NovaBridge Biosciences (NBP) United States $0.461B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.455B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.454B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.446B 0.00
Design Therapeutics (DSGN) United States $0.431B 0.00
Cullinan Therapeutics (CGEM) United States $0.425B 0.00
Ocugen (OCGN) United States $0.425B 0.00
PureTech Health (PRTC) United States $0.423B 0.00
Neumora Therapeutics (NMRA) United States $0.415B 0.00
Bright Minds Biosciences (DRUG) United States $0.414B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
XOMA Royalty (XOMA) United States $0.401B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.388B 0.00
Kamada (KMDA) Israel $0.383B 19.59
Neurogene (NGNE) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Invivyd (IVVD) United States $0.370B 0.00
Tectonic Therapeutic (TECX) United States $0.362B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.354B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Benitec Biopharma (BNTC) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.332B 0.00
AC Immune (ACIU) Switzerland $0.331B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Contineum Therapeutics (CTNM) United States $0.319B 0.00
Annexon (ANNX) United States $0.316B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Alto Neuroscience (ANRO) United States $0.313B 0.00
EnGene Holdings (ENGN) Canada $0.310B 0.00
DiaMedica Therapeutics (DMAC) United States $0.306B 0.00
Puma Biotechnology (PBYI) United States $0.302B 8.09
Jade Biosciences (JBIO) United States $0.300B 0.00
Immuneering (IMRX) United States $0.286B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.286B 0.00
Kyverna Therapeutics (KYTX) United States $0.285B 0.00
Candel Therapeutics (CADL) United States $0.277B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
BioAge Labs (BIOA) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.260B 0.00
Atea Pharmaceuticals (AVIR) United States $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.249B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Sagimet Biosciences (SGMT) United States $0.245B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.237B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Cabaletta Bio (CABA) United States $0.233B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Palisade Bio (PALI) United States $0.223B 0.00
Editas Medicine (EDIT) United States $0.222B 0.00
Black Diamond Therapeutics (BDTX) United States $0.222B 10.81
Aardvark Therapeutics (AARD) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.215B 0.00
Humacyte (HUMA) United States $0.211B 0.00
Tenaya Therapeutics (TNYA) United States $0.209B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.208B 0.00
Genelux (GNLX) United States $0.206B 0.00
Cartesian Therapeutics (RNAC) United States $0.205B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.204B 0.00
SELLAS Life Sciences (SLS) United States $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
Caribou Biosciences (CRBU) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Molecular Partners AG (MOLN) Switzerland $0.191B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Crescent Biopharma (CBIO) United States $0.182B 0.00
C4 Therapeutics (CCCC) United States $0.167B 0.00
Innate Pharma S.A (IPHA) France $0.164B 0.00
Coherus Oncology (CHRS) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
MaxCyte (MXCT) United States $0.154B 0.00
Codexis (CDXS) United States $0.153B 0.00
PepGen (PEPG) United States $0.152B 0.00
Forte Biosciences (FBRX) United States $0.150B 0.00
Cognition Therapeutics (CGTX) United States $0.147B 0.00
Cardiff Oncology (CRDF) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Rani Therapeutics Holdings (RANI) United States $0.145B 0.00
Elicio Therapeutics (ELTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Entera Bio (ENTX) Israel $0.143B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Anika Therapeutics (ANIK) United States $0.142B 0.00
Alector (ALEC) United States $0.140B 0.00
Nkarta (NKTX) United States $0.139B 0.00
Spero Therapeutics (SPRO) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.138B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
TuHURA Biosciences (HURA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Agenus (AGEN) United States $0.127B 0.00
Climb Bio (CLYM) United States $0.125B 0.00
Fate Therapeutics (FATE) United States $0.123B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.123B 0.00
VistaGen Therapeutics (VTGN) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
Alpha Cognition (ACOG) Canada $0.120B 0.00
Seer (SEER) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.117B 0.00
Citius Oncology (CTOR) United States $0.117B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
Turn Therapeutics (TTRX) United States $0.113B 0.00
Estrella Immunopharma (ESLA) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.104B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.102B 0.00
Instil Bio (TIL) United States $0.102B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.099B 0.00
Clene (CLNN) United States $0.099B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Tevogen Bio Holdings (TVGN) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Biomea Fusion (BMEA) United States $0.097B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Starpharma Holdings (SPHRY) Australia $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Ovid Therapeutics (OVID) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
OKYO Pharma (OKYO) $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.090B 0.00
Kalaris Therapeutics (KLRS) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.086B 0.00
CAMP4 Therapeutics (CAMP) United States $0.086B 0.00
Artiva Biotherapeutics (ARTV) United States $0.085B 0.00
Quince Therapeutics (QNCX) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
Precision BioSciences (DTIL) United States $0.081B 0.00
ATyr Pharma (ATYR) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
XBiotech (XBIT) United States $0.071B 0.00
Immunic (IMUX) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Adagene (ADAG) China $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.066B 0.00
Equillium (EQ) United States $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Spruce Biosciences (SPRB) United States $0.064B 0.00
BioStem Technologies (BSEM) $0.062B 3.26
TScan Therapeutics (TCRX) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Radiopharm Theranostics - (RADX) Australia $0.046B 0.00
Hyperion DeFi (HYPD) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.044B 0.00
Genenta Science S.p.A (GNTA) Italy $0.044B 0.00
CalciMedica (CALC) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.043B 0.00
INmune Bio (INMB) United States $0.043B 0.00
PDS Biotechnology (PDSB) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
X4 Pharmaceuticals (XFOR) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
BioAtla (BCAB) United States $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Elutia (ELUT) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
Generation Bio (GBIO) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Tharimmune (THAR) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Synaptogenix (TAOX) United States $0.029B 0.00
Jasper Therapeutics (JSPR) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
IBio (IBIO) United States $0.027B 0.00
Rallybio (RLYB) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
NextCure (NXTC) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.023B 0.00
MetaVia (MTVA) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
NewcelX (NCEL) Switzerland $0.018B 0.00
FibroBiologics (FBLG) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Apollomics (APLM) United States $0.016B 0.00
Longeveron (LGVN) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Dogwood Therapeutics (DWTX) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BRIACELL THERAP (BCTX) Canada $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.21
GT Biopharma (GTBP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00